Monday February 24, 2020

Perrigo acquires a number of GlaxoSmithKline brands

7th June, 2015
6
Perrigo: move aims to capture a greater share of the European market

Pharmaceutical company Perrigo has bought a number of over-the-counter European brands from GlaxoSmithKline.

“We are building on the global platform we established with the Omega Pharma acquisition to capture an even greater share of the $30 billion European OTC market opportunity with several well-established, complementary brands that bolster our OTC product portfolio.”

Joseph C Papa, Perrigo chairman, president and chief executive

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader

Trial

€1

Unlimited Access for 1 Month

Then €19.99 a month after the offer period.

Get basic
*New subscribers only
You can cancel any time.

Annual

€200

€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.

Quarterly

€55

€42

90 Day Pass

You can cancel any time.

Team Pass

Get a Business Account for you and your team

Related Stories

What’s coming up today and what you might have missed

Hannah O’Brien | 2 months ago

What’s coming up today and what you might have missed.

Hannah O’Brien | 2 months ago